Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

2 months ago 6860

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Read Entire Article

Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

Related

'Millisecond' preconfirmations make it to Ethereum via new R...

Crypto bill deliberation reaches fever pitch between industr...

Citadel CEO discloses massive stake in Solana treasury compa...

Congress moves to revamp Bank Secrecy Act’s reporting thresh...

Bitcoin wants to go up, but Trump’s tariffs aren’t helping: ...

Google announces quantum advantage, 13,000 times faster than...

Trending

Popular

Fidelity Buys $154.6M in Ethereum as Analysts Predict Move T...

Bitcoin Bull Run Coming To An End: Cycle Peak Countdown Sign...

Bear Market Alert: Top Expert Claims Bitcoin Price Fate Hang...

Beijing says it has “irrefutable evidence” that the U.S. NSA...

Analyst Sounds Alarm: Ethereum Could Unwind To $2,850

Analyst Uses AI To Show How The XRP Price Could Rally To $1,...

Ocean Protocol, Fetch AI caught in a dispute stemming from O...